Research activity

Here is a list of all the research activity pages:

Generic List

For Investigators

Description
ASTRAL is a multicentre, randomized, unblinded clinical trial, comparing revascularisation in addition to medical therapy versus medical therapy alone in patients with atherosclerotic renovascular disease (ARVD). The aim of ASTRAL is to assess whether renal arterial revascularisation with balloon angioplasty and/or endovascular stenting can safely prevent progressive renal failure among patients with ARVD. ASTRAL closed to recruitment in October 2007 having recruited 806 patients, and is now in long term follow up until 2017. The trial is managed by the BCTU at the University of Birmingham.

For Investigators

Description
GloMY is a national, multicentre, randomised controlled open-label pilot trial of Myfortic plus short course steroids versus standard care in patients with FSGS and IgAN. The aim of GloMY is to determine the feasibility of running a full-scale phase III randomised trial. It is managed by the BCTU at the University of Birmingham.

For Investigators

Description
Index page for Investigators section of the EXTOD trial site. featuring trial documentation, recent publications and information on recruitment.

For Investigators

Description
PREDNOS 2 is a national multicentre randomised double blind trial of short course daily prednisolone therapy at the time of upper respiratory tract infection (URTI) in children with relapsing steroid sensitive nephrotic syndrome (SSNS). The aim of the study is to evaluate the effectiveness of a six day course of daily prednisolone therapy at the time of URTI in reducing the development of subsequent nephrotic syndrome relapse in children with relapsing SSNS.

For Investigators

Description
The PD COMM Pilot study is a multi centre clinical trial pilot ran by Birmingham Clinical Trials Unit and sponsored by the University of Birmingham. Its aim is to evaluate the feasibility of a full scale trial on the effectiveness and cost-effectiveness of two types of speech and language therapy for people with Parkinson's disease who have self reported problems with voice or speech – standard NHS therapy and Lee Silverman Voice Training

For Investigators

Description
PD GEN is a DNA databank for patients with Parkinson's, from the large randomised controlled trials PD MED, PD SURG, PD REHAB & PD COMM.

For Investigators

Description
PD MED is a large randomised clinical trial investigating the clinical and cost effectiveness of the different classes of drugs in the treatment of patients with Parkinson's disease.

For Investigators

Description
The PD REHAB study is a multi centre clinical trial ran by Birmingham Clinical Trials Unit and sponsored by the University of Birmingham. It's an investigation into the clinical and cost-effectiveness of physiotherapy and occupational therapy in patients with Parkinson's.
Displaying 31 to 40 of 79
Previous 2 3 4 5 6 Next